Pharma & Biotech

X4 Pharmaceuticals is undergoing a profound corporate transformation, marked by a complete overhaul of its executive leadership and the successful...

Dyne Therapeutics Inc finds itself at a pivotal crossroads as two significant events converge this week. The biotechnology firm, whose...

Soleno Therapeutics finds itself at a dramatic crossroads, caught between a landmark commercial launch and a storm of allegations that...

Viking Therapeutics Inc. has experienced extreme stock volatility after announcing results from a key clinical study for its obesity treatment...

Ultragenyx Pharmaceutical finds itself under legal investigation following a significant stock decline in late July. The Pomerantz Law Firm has...

As the United States continues its battle against the devastating opioid crisis, Emergent BioSolutions is pursuing a distinctive strategy that...

Precision BioSciences Inc. shares extended their recent decline, closing the latest trading session with significant losses. The clinical-stage biotechnology company's...

Investors in Ionis Pharmaceuticals experienced a surprising market reaction following the long-awaited FDA approval of Dawnzera. Instead of triggering a...

While numerous biotech equities continue to struggle in weak markets, Arcus Biosciences is demonstrating a notable trend: major institutional investors...

Oric Pharmaceuticals Inc is entering a pivotal period, with a series of key investor conferences scheduled for September designed to...